• CROI: Results from a PrEP Demonstration Project for At-Risk Cisgender Women in the US - PrEP/PEP at CROI (04/04/20)
   
  
• CROI: DOLUTEGRAVIR USE IS ASSOCIATED WITH HIGHER POSTPARTUM WEIGHT COMPARED TO EFAVIRENZ (04/04/20)
   
  
• CROI: GREATER INCIDENCE OF DIABETES OVER 10 YEARS AMONG DEPRESSED US VETERANS WITH HIV (04/04/20)
   
  
• CROI: Diabetes, Weight Gain, & Integrase Inhibitor Use in North American HIV+ Persons (04/04/20)
   
  
• CROI: Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Disease "LIFE HIV Study" (04/04/20)
   
  
• CROI: Low-level viremia during ART and the risk of death, AIDS, and serious non-AIDS events (04/04/20)
   
  
• CROI: EFFECTS OF VIRAL LOAD ON NEUROIMAGING AND NEUROPSYCHOLOGICAL PERFORMANCE (04/04/20)
   
  
• CROI: EXPLAINING RACIAL DISPARITIES IN VIRAL SUPPRESSION AMONG MSM LIVING WITH HIV (04/04/20)
   
  
• CROI: EXPLOSIVE HIV AND HCV EPIDEMICS DRIVEN BY NETWORK VIREMIA (04/04/20)
   
  
• CROI: Long Island has 6,649 cases with both counties combined. (04/04/20)
   
  
• CROI: HCV INCIDENCE AMONG HIV-INFECTED MSM IN FRANCE: RESULTS FROM THE FHDH-ANRS CO4 COHORT (04/04/20)
   
  
• CROI: Clinical Features and Outcomes of Patients Stopping DTG for Neuropsychiatric Symptoms (04/04/20)
   
  
More HIV Articles...
 

• Coronavirus puts drug repurposing on the fast track - (03/02/20)
   
  
• FDA Expands Coronavirus Testing in the United States - (03/02/20)
   
  
• Vice President Pence Announces Ambassador Debbie Birx to Serve as the White House Coronavirus Response Coordinator - (02/27/20)
   
  
• Fauci on Coronavirus: nearly at the brink - (02/24/20)
   
  
More News Updates Articles...
 

• HCV & HCV/HIV Coinfection Micro-Elimination Grants: funding for 30+ projects - -
   
  
• EASL: Summary from EASL 2018 for Hepatitis C (HCV) HCV in 2018: Success stories and remaining challenges? - Prof. Dr. J.K. Rockstroh Department of Medicine I University of Bonn Sigmund-Freud-Str. 25 53105 Bonn Germany-
   
  
• EASL: HCV Micro-Elimination Funding Grants Available
   
  
• CROI: HPTN 078: HIGH INCIDENCE OF HEPATITIS C VIRUS INFECTIONS AMONG MSM (04/02/20)
   
  
• CROI: HEPATITIS C VIRUS INFECTION AND COINFECTION WITH HIV AMONG PWID IN 10 US CITIES (04/02/20)
   
  
• CROI: Mobile HCV Screening in At-Risk Urban Population Identifies Significant Fibrosis (04/02/20)
   
  
• CROI: HCV REINFECTION AFTER DAA TREATMENT AMONG PEOPLE LIVING WITH HIV IN SAN DIEGO (04/02/20)
   
  
• CROI: HCV TRANSMISSION AMONG MSM: EXTERNAL INTRODUCTIONS COULD COMPLICATE MICRO-ELIMINATION (04/02/20)
   
  
• CROI: INVESTIGATION OF CLASSIC AND HIV-RELATED FACTORS FOR HEPATIC STEATOSIS AMONG PWID - 20% ALIVE Cohort (04/02/20)
   
  
• CROI: SEX, NOT DRUG USE, IS DRIVING HCV RE-INFECTION AMONG HIV-INFECTED MSM IN NEW YORK CITY (03/30/20)
   
  
• CROI: Hepatic Fibrosis Determined with MRE Significantly Predicts Cognitive Impairment (03/30/20)
   
  
• CROI: Hepatitis C Coinfection and Extrahepatic Cancer Incidence among People with HIV (03/30/20)
   
  
• CROI: HCV, Opioid Use, Psych Illness Cluster in Veterans Group--Treatment of Opioid Use Very Low (03/30/20)
   
  
• CROI: HCV Retreatment, Multiple DAA Failures - Case Study (03/18/20)
   
  
• CROI: Real-world effectiveness of Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection (03/18/20)
   
  
• CROI: Real-world effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C Virus Infection (03/18/20)
   
  
More Hep C Articles...
 

• CROI: HBV New Agents (04/02/20)
   
  
• CROI: Replicor announces publication of the REP 401 study achieving high rates of virologic control and functional cure in patients with chronic hepatitis B infection (04/02/20)
   
  
• HBV Cure Therapies Research - (01/23/20)
   
  
• AASLD: Impact of Prior Tenofovir Disoproxil Fumarate Treatment Duration on Tenofovir Alafenamide Safety Profile in Virally Suppressed, Chronic HBV Patients Switched From TDF to TAF - (12/13/19)
   
  
• AASLD: Efficacy and Safety of Oral TLR8 Agonist Selgantolimod in Virally Suppressed Adult Patients With Chronic Hepatitis B: a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study - (12/12/19)
   
  
More Hep B Articles...
 

List not necessarily listed here in order of date being held.